サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1770157

Gタンパク質共役受容体（GPCRs）の世界市場

G-Protein Coupled Receptors (GPCRs)

出版日
ページ情報
英文 359 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
Gタンパク質共役受容体（GPCRs）の世界市場
出版日: 2025年07月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 359 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Gタンパク質共役受容体（GPCRs）の世界市場は2030年までに51億米ドルに達する見込み

2024年に36億米ドルと推定されるGタンパク質共役受容体（GPCRs）の世界市場は、2024年から2030年にかけてCAGR 6.2%で成長し、2030年には51億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである細胞ラインは、CAGR 6.1％を記録し、分析期間終了までに19億米ドルに達すると予測されます。検出キット分野の成長率は、分析期間中CAGR 6.7%と推定されます。

米国市場は12億米ドルと推定、中国はCAGR 8.8％で成長予測

米国のGタンパク質共役受容体（GPCRs）市場は2024年に12億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを8.8%として、2030年までに4億1,690万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.2%と6.1%と予測されています。欧州では、ドイツがCAGR 5.8%で成長すると予測されています。

世界のGタンパク質共役受容体（GPCRs）市場- 主要動向と促進要因まとめ

Gタンパク質共役受容体（GPCRs）は、細胞内シグナル伝達において重要な役割を果たす、膨大かつ多様な膜タンパク質群です。これらの受容体は、ホルモン、神経伝達物質、環境刺激物質などの様々な細胞外シグナルに反応することで、幅広い生理的プロセスに関与しています。GPCRは7つの膜貫通らせんによって構造的に特徴付けられ、Gタンパク質との結合と活性化を通して細胞内シグナル伝達経路を活性化します。この活性化は、視覚、味覚、嗅覚、免疫反応などの重要な機能を制御する下流作用のカスケードを引き起こします。GPCRの多様性と偏在性により、GPCRは細胞コミュニケーションと薬理学の研究の焦点となっています。

GPCRの重要性は治療開発にも及んでおり、現代医薬の大部分がGPCRを標的としています。FDAに認可された医薬品の約34％がGPCRを標的としており、その治療的可能性を強調しています。これらの医薬品は、心血管疾患、精神疾患、がんを含む様々な疾患の治療に使用されています。低温電子顕微鏡やX線結晶構造解析などの構造生物学の進歩により、GPCRの構造に関する詳細な知見が得られ、より選択的で効果的な薬剤の設計が容易になりました。さらに、アロステリックモジュレーションやバイアスアゴニズムといった新しいアプローチは、リガンドに対する受容体の反応を微調整することで、効能が向上し副作用の少ない薬剤を開発する機会を提供しています。

GPCR市場の成長は、いくつかの要因によってもたらされます。技術の進歩により、GPCRの構造や機能に対する理解が著しく深まり、より的を絞った効率的な医薬品開発プロセスにつながっています。慢性疾患の有病率の増加と、より効果的な治療法の必要性が、GPCRを標的とした新しい治療法に対する需要を促進しています。さらに、製薬業界が個別化医療に注力し、個々の疾病状態に関連する特定のGPCRを同定することで、オーダーメイドの治療介入の開発に拍車がかかっています。ハイスループット・スクリーニング技術やコンピュータ創薬ツールの拡大により、潜在的なGPCRモジュレーターの同定が加速しています。さらに、学術機関、バイオテクノロジー企業、製薬大手間の協力的な取り組みにより、GPCR研究と医薬品開発は大きく進展しています。GPCRに対する理解が深まり、新たな技術が登場するにつれて、GPCR標的治療薬市場は力強い成長を遂げ、さまざまな疾患領域でアンメット・メディカル・ニーズに対応し、患者の予後を改善することが期待されています。

セグメント

製品タイプ（細胞株、検出キット、細胞培養試薬、リガンド）、アッセイタイプ（cAMP機能アッセイ、カルシウム機能アッセイ、B-アレスチン機能アッセイ、放射性リガンド結合・GTPyS機能アッセイ、インターナイゼーションアッセイ、その他アッセイタイプ）、アプリケーション（がん研究、代謝研究、炎症研究、中枢神経系研究、呼吸器系研究、循環器系研究、その他アプリケーション）

調査対象企業の例

  • Merck KGaA
  • BD Biosciences
  • Enzo Life Sciences, Inc.
  • Lexicon Pharmaceuticals, Inc.
  • Molecular Devices LLC
  • Aragen Life Sciences Pvt. Ltd.
  • Axxam SpA
  • Abcam PLC
  • Eurofins Scientific SE
  • HD Biosciences Co., Ltd.
  • Addex Therapeutics
  • Multispan, Inc.
  • Creative Biolabs
  • Beacon Discovery
  • Distributed Bio

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP-6269

Global G-Protein Coupled Receptors (GPCRs) Market to Reach US$5.1 Billion by 2030

The global market for G-Protein Coupled Receptors (GPCRs) estimated at US$3.6 Billion in the year 2024, is expected to reach US$5.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Cell Lines, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.9 Billion by the end of the analysis period. Growth in the Detection Kits segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.8% CAGR

The G-Protein Coupled Receptors (GPCRs) market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$416.9 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global G-Protein Coupled Receptors (GPCRs) Market - Key Trends & Drivers Summarized

G-Protein Coupled Receptors (GPCRs) are a vast and diverse group of membrane proteins that play crucial roles in cellular signal transduction. These receptors are involved in a wide array of physiological processes by responding to various extracellular signals, including hormones, neurotransmitters, and environmental stimulants. Structurally characterized by their seven transmembrane helices, GPCRs activate intracellular signaling pathways through the binding and activation of G-proteins. This activation triggers a cascade of downstream effects that regulate essential functions such as vision, taste, smell, and immune responses. The versatility and ubiquity of GPCRs make them a focal point in the study of cellular communication and pharmacology.

The significance of GPCRs extends into therapeutic development, as they are prominent targets for a large proportion of modern pharmaceuticals. Approximately 34% of all FDA-approved drugs target GPCRs, underscoring their therapeutic potential. These drugs are used to treat a variety of conditions, including cardiovascular diseases, mental health disorders, and cancers. Advances in structural biology, such as cryo-electron microscopy and X-ray crystallography, have provided detailed insights into GPCR structures, facilitating the design of more selective and effective drugs. Furthermore, novel approaches like allosteric modulation and biased agonism offer opportunities to develop drugs with improved efficacy and fewer side effects by fine-tuning the receptor's response to ligands.

The growth in the GPCR market is driven by several factors. Technological advancements have significantly enhanced our understanding of GPCR structures and functions, leading to more targeted and efficient drug development processes. The increasing prevalence of chronic diseases and the need for more effective treatments drive the demand for new GPCR-targeted therapies. Additionally, the pharmaceutical industry's focus on personalized medicine and the identification of specific GPCRs associated with individual disease states has spurred the development of tailored therapeutic interventions. The expansion of high-throughput screening techniques and computational drug discovery tools has accelerated the identification of potential GPCR modulators. Furthermore, collaborative efforts between academic institutions, biotechnology companies, and pharmaceutical giants have facilitated significant progress in GPCR research and drug development. As the understanding of GPCRs continues to deepen and new technologies emerge, the market for GPCR-targeted therapies is expected to experience robust growth, addressing unmet medical needs and improving patient outcomes across various disease areas.

SCOPE OF STUDY:

The report analyzes the G-Protein Coupled Receptors (GPCRs) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands); Assay Type (cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays, Other Assay Types); Application (Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Merck KGaA
  • BD Biosciences
  • Enzo Life Sciences, Inc.
  • Lexicon Pharmaceuticals, Inc.
  • Molecular Devices LLC
  • Aragen Life Sciences Pvt. Ltd.
  • Axxam SpA
  • Abcam PLC
  • Eurofins Scientific SE
  • HD Biosciences Co., Ltd.
  • Addex Therapeutics
  • Multispan, Inc.
  • Creative Biolabs
  • Beacon Discovery
  • Distributed Bio

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • G-Protein Coupled Receptors (GPCRs) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • GPCR: An Introduction
    • Important Role of GPCRs in Drug Discovery
    • Popular Types of GPCRs of Therapeutic Interest
    • Classification of GPCRs
    • Orphan GPCRs: A Promising Area for Drug Discovery
    • GPCR Signaling Pathways
    • Physiological Roles Performed by GPCRs
    • Outlook
    • Geographic Market Analysis
    • Challenges
    • Competition
    • Recent Market Activity
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Therapeutic Potential of GPCRs Gains Wide Recognition
    • Allosteric Modulators and Implication of Allostery in Drug Discovery
    • GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL, IUPHAR, and The DrugBank
    • GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL
    • GPCRs Registered as Targets for Approved Drugs with International Union of Basic and Clinical Pharmacology (IUPHAR)
    • GPCRs Registered as Targets for Approved Drugs with The DrugBank
    • Hurdles Faced...
    • Developments in Structural Biology and Receptor Pharmacology Offer Novel Opportunities to GPCR Drug Discovery
    • In Silico Approaches Underway for GPCR Drug Screening
    • Microfluidic Cell Technology Holds Potential
    • Pipeline GPCR Drug Candidates Widen Prospects
    • Select GPCR Small Molecule Drugs in Active Clinical Development
    • GPCR Ligands (Agonist) in Phase III Clinical Development
    • GPCR Ligands (Antagonist) in Phase III Clinical Development
    • New Indications to Aid Growth
    • CRISPR Holds Potential to Speed Up GPCR-based Drug Discovery
    • GPCR-targeted Drugs and Role in Cancer Treatment
    • Select FDA Approved Drugs and Antibodies against Various Cancer Types
    • Potential GPCR targets for Cancer Treatment
    • Anti GPCRs Drugs and Antibodies under Clinical Trials
    • Rising Incidence of Cancer to Drive Drives Opportunities
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • GPCRs Evolve as Important targets for developing novel therapeutics for Neurodegerative Disorders
    • Number of Individuals Suffering from Alzheimer's in the US: 2020 and 2025
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • GPCRs: An Important Target for Cardiovascular Drugs
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • GPCR Screening and Targeting Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cell Lines by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Detection Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cell Culture Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Ligands by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for cAMP Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Calcium Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for B-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for B-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for B-Arrestin Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Radioligand Binding & GTPyS Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Internalization Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Assay Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Metabolic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Inflammation Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 44: World Historic Review for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 45: World 15-Year Perspective for CNS Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 48: World 15-Year Perspective for Respiratory Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 49: World Recent Past, Current & Future Analysis for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 50: World Historic Review for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 51: World 15-Year Perspective for Cardiovascular Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 52: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 53: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 54: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 55: World G-Protein Coupled Receptors (GPCRs) Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: USA 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 65: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 83: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 113: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION